Fulcrum Therapeutics, Inc. (FULC)

10.03 -0.35 (-3.37%) USD  |  NASDAQ  |  Jan 16, 15:50
More

Fulcrum Therapeutics Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for FULC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Agios Pharmaceuticals, Inc. Upgrade
Biogen, Inc. Upgrade
CorMedix, Inc. Upgrade
Apellis Pharmaceuticals, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade